Diabetic neuropathic foot ulcers: The association of wound size, wound duration, and wound grade on healing

Diabetes Care

Volumn 25, Issue 10, 2002, Pages 1835-1839

  Margolis, David J ^a   Allen Taylor, Lynne ^a   Hoffstad, Ole ^a   Berlin, Jesse A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CORRELATION ANALYSIS; DIABETIC NEUROPATHY; EVALUATION; FOOT ULCER; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; RISK FACTOR; WOUND HEALING; AGED; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; DIABETIC FOOT; FEMALE; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS; TIME;

AGED; COHORT STUDIES; DIABETIC FOOT; DIABETIC NEUROPATHIES; FEMALE; FOOT ULCER; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; TIME FACTORS; WOUND HEALING;

EID: 0036782872     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.10.1835     Document Type: Article

References (25)

1. National Diabetes Data Group: Diabetes in America. Vol. 2. Bethesda, MD, National Institutes of Health, 1995 (NIH publ. no. 95-1468)
2. McNeely MJ, Boyko EJ, Ahroni JH, Stensel VL, Reiber GE, Smith DG, Pecoraro RE: The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. Diabetes Care 18:216-219, 1995
3. Reiber GE: The epidemiology of diabetic foot problems. Diabetic Medicine 13:S6-S11, 1998
4. Brod M: Quality of life issues in patients with diabetes and lower extremity ulcers: patients and care givers. Qual Life Res 7:365-372, 1998
5. Ashry HR, Lavery LA, Armstrong DG, Lavery DC, van Houtum WH: Cost of diabetes-related amputations in minorities. J Foot Ankle Surg 37:186-190, 1998
6. Reiber GE, Vileikyte L, Boyko EJ, del Aguila M, Smith DG, Lavery LA, Boulton AJ: Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 22:157-162, 1999
7. Tannenbaum GA, Pomposelli FB, Marcaccio EJ, Gibbons GW, Campbell DR, Freeman DV, Miller A, LoGerfo FW: Safety of vein bypass grafting to the dorsal pedal artery in diabetic patients with foot infections. J Vasc Surg 15:982-990, 1992
8. Gentzkow GD, Iwasaki SD, Hershon KS, Mengel M, Prendergast JJ, Ricotta JJ, Steed DP, Lipkin S: Use of Dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 19:350-354, 1996
9. Wieman TJ, Smiell JM, Su Y: Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. Diabetes Care 21:822-827, 1998
10. Veves A, Falanga V, Armstrong DG, Sabolinski ML, Apligraf Diabetic Foot Ulcer Study: Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective, randomized multicenter clinical trial. Diabetes Care 24:290-295, 2001
11. American Diabetes Association: Consensus development conference on diabetic wound care. Diabetes Care 22:1354-1360, 1999
12. Steed DL: Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J Vasc Surg 21:71-78, 1995
13. Weiman TJ, Griffiths GD, Polk HC: Management of diabetic midfoot ulcers. Ann Surg 215:627-632, 1992
14. Steed DL: Foundations of good ulcer care. Am J Surg 176 (Suppl. 2A):20S-25S, 1998
15. Margolis DJ, Kantor J, Berlin JA: Healing of diabetic neuropathic foot ulcers receiving standard treatment: a meta analysis. Diabetes Care 22:692-695, 1999
16. Steed DL, Goslen JB, Holloway GA, Malone JM, Bunt TJ, Webster MW: Randomized prospective double-blinded trial in healing chronic foot ulcers. Diabetes Care 15:1598-1604, 1992
17. Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA: Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 24:483-488, 2001
18. Kantor J, Margolis DJ: The accuracy of using a wound care specialty clinic database to study diabetic neuropathic foot ulcers. Wound Repair Regen 8:169-173, 2000
19. Begaud B, Moride Y, Tubert-Bitter P, Chaslerie A, Haramburu F: False-positives in spontaneous reporting: should we worry about them?. Br J Clin Pharmacol 38:401-404, 1994
20. Rabe-Hesketh S, Pickles A, Skrondal A: GLLAMM Manual. London, Institute of Psychiatry, King's College, University of London, 2001
21. Steed DL, Donohoe D, Webster MW, Lindsley L: Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Amer Coll Surgeons 183:61-64, 1996
22. Maldonado G, Greenland S: Simulation study of confounder-selection strategies. Amer J Epidemiol 138:923-936, 1993
23. Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Armstrong DG, Harkless LB, Boulton AJ: The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med 18:133-138, 2001
24. Margolis DJ, Kantor J, Samanna J, Strom BL, Berlin JA: Risk factors for delayed healing of neuropathic diabetic foot ulcers: a pooled analysis. Arch Dermatol 136:1531-1535, 2000
25. Margolis DJ, Berlin JA, Strom BL: Risk factors associated with the failure of a venous leg ulcer to heal. Arch Dermatol 135:920-926, 1999